Elevation Oncology, Inc.
NASDAQ:ELEV
0.5108 (USD) • At close March 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 49.464 | 49.255 | 45.917 | 146.284 | 79.4 | 1.74 |
| Short Term Investments
| 43.72 | 33.852 | 44.363 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 93.184 | 83.107 | 90.28 | 146.284 | 79.4 | 1.74 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.542 | 4.857 | 2.697 | 6.28 | 1.386 | 0.174 |
| Total Current Assets
| 94.726 | 87.964 | 92.977 | 149.424 | 80.786 | 1.914 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.034 | 0.059 | 0.098 | 0.038 | 0.056 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.866 | 1.068 | 1.086 | 0.032 | 0.065 | 0 |
| Total Non-Current Assets
| 0.9 | 1.127 | 1.184 | 0.07 | 0.121 | 0 |
| Total Assets
| 95.626 | 89.091 | 94.161 | 149.494 | 80.907 | 1.914 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0.559 | 0.507 | 6.362 | 5.648 | 5.679 | 0.46 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 3.908 | 3.638 | 9.33 | 3.141 | 1.106 | 0.137 |
| Total Current Liabilities
| 4.467 | 4.145 | 15.692 | 8.789 | 6.785 | 0.597 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 31.134 | 30.137 | 29.435 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0.002 | 0.008 | 97.203 | 0 |
| Total Non-Current Liabilities
| 31.134 | 30.137 | 29.437 | 0.008 | 97.203 | 7.19 |
| Total Liabilities
| 35.601 | 34.282 | 45.129 | 8.797 | 103.988 | 7.787 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 94.161 | 149.494 | 97.188 | 7.19 |
| Common Stock
| 0.006 | 0.004 | 0.002 | 0.002 | 0 | 0 |
| Retained Earnings
| -240.455 | -195.97 | -150.266 | -55.186 | -23.147 | -5.882 |
| Accumulated Other Comprehensive Income/Loss
| 0.061 | 0.009 | -0.161 | -149.494 | 0 | -0 |
| Other Total Stockholders Equity
| 300.413 | 250.766 | 199.457 | 46.387 | -97.122 | -7.181 |
| Total Shareholders Equity
| 60.025 | 54.809 | 49.032 | 140.697 | -23.081 | -5.873 |
| Total Equity
| 60.025 | 54.809 | 49.032 | 140.697 | -23.081 | -5.873 |
| Total Liabilities & Shareholders Equity
| 95.626 | 89.091 | 94.161 | 149.494 | 80.907 | 1.914 |